A Trial Investigating the Effects of Semaglutide on ß-cell Function in Subjects With Type 2 Diabetes
Clinical trial NCT02212067 · COMPLETED
Trial details
- NCT number
- NCT02212067
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-11
- Primary completion
- 2015-05-11
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.